One of the most common neoplasms in the world, ranking third, is the colorectal cancer. 96% of all cases of colorectal cancer are adenocarcinoma. The prognostic of this diagnostic is a bad one, with low 5-years survival rate. Although the most common locations for the metastases are the liver and the lungs, the bones can also be targeted (5.5%). We present the case of a 65-year-old male who came to the hospital with pain and tumefaction at the right fibular head. After extensive clinical and paraclinical examinations, a biopsy was performed, at which stage the entire tumor was removed. The result was that of moderate differentiated adenocarcinoma. The patient was then further examined and a tumor was discovered at the sigmoid colon. The primary tumor was removed and the patient underwent oncological treatment. 2 years later, the patient returned with a recurrence of the bone metastasis. After a PET-CT that infirmed other metastases coupled with a satisfactory evolution of the primary tumor, the decision was made to amputate the knee above. Biopsy is an essential step that establishes the correct diagnostic and dictates the right choice of treatment solution. Counseling is also essential, so that the patient can choose and accept the best treatment option.
Introduction
The colorectal cancer is one of the most common types of cancer worldwide, ranking third, with an estimated 1.2 million new cases diagnosed worldwide every year. 96% of all colorectal cancers are adenocarcinoma. Studies in the US show that approximately 4.6% of men and 4.2% of women will be diagnosed with CRC in their lifetime [14, 15] .
The distribution between men and women is close to equal with a slight incline to the male gender. The median age of diagnosis for colon cancer is 68 years for men and 72 years for women, and a median age of 63 years for rectal cancer for both men and women [11, 19, 20] . The risk factors for developing colorectal cancer are multiple and various, ranging from genetic (specific gene mutations that associate other syndromes, such as Lynch syndrome, familial adenomatous polyposis, with a higher risk for colorectal cancer) to personal medical history (chronic inflammatory bowel disease, diabetes) to behavioral factors (physical inactivity, overweight and obesity, diet, smoking, alcohol) [7, 12, 21] . The treatment options depend on the stage of the cancer and can be curative or palliative. When discovered in late stages, it is imperative to search for secondary determinations. The most common sites for metastases are the liver and the lungs, but other locations can be affected, such as the peritoneum, the ovaries, and in some cases, the bones [1] [2] [3] .
Case report
In January 2015, a 65-year-old patient came to our Clinic at the Emergency University Hospital of Bucharest with pain and a tumefaction matching the site of the right fibular head. The patient stated that the tumefaction grew over a period of 6 months. However, the pain only began approximately 1 month before the patient went to the hospital. The lack of any recent traumatic history and the growing tumefaction coupled with the pain that did not subside with any anti-inflammatory treatment, urging the patient to go to the hospital. Upon arrival, a preliminary set of investigations were made (blood tests and a simple right knee X-ray). The X-ray showed a tumoral growth of the fibular head. This was followed by the minute investigation of the patient ( After careful planning and preparation, a biopsy was performed in January 2015 (Fig.  4) . During the surgery, the entire tumor was removed. The histopathology result that arrived was strange, as it was indicating a moderate differentiated adenocarcinoma. Upon learning this result, the patient was scheduled for a whole body CT-scan that revealed a tumor of the sigmoid colon (Fig. 3) . The patient was subjected to surgery and the colon tumor was removed. Subsequently, he started chemotherapy in the Oncological Department of our Hospital. There, he was subjected to chemotherapy with a personal treatment with 5-fluorouracil, leucovorin, and oxaliplatin. After a 2-year period, the patient returned to our Clinic with a tumefaction on the biopsy site. An X-ray of the right knee showed the recurrence of the tumor, with a bigger volume than the previous lesion (Fig. 5) .
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Fig. 5 X-rays highlighting the recurrence of the metastasis
At that respective moment, the patient was still undergoing the oncological treatment. A PET-CT was performed and the result infirmed other metastases. After interdisciplinary consulting, the decision was made to amputate from the distal femur. The reasoning for this decision was the absence of other metastases, the favorable evolution of the primary tumor site, as well as the highest survival rate chance. The patient was informed of all aspects and gave his consent for the surgery. In November 2017, the amputation of the distal femur was performed. Post-surgery, the evolution was favorable. The follow-ups were at 12 days, 6 weeks, 3 months and are still ongoing.
Discussions
The particularity of this case was the recurrence of the metastasis although chemotherapy was administered. The bone metastasis of a colorectal cancer is in itself a rare location, but this was not always the case. Before the introduction of modern chemotherapy, bone metastases were reported in 10-24% of colorectal cancers [22, 23] . Nowadays, this percentage is lower (5.5%), but still controversial. The overall survival period was raised with said new chemotherapy drugs and targeted treatments, and thus the chance for a bone metastasis to develop also increased. The location of the metastasis was also a particularity of this case, the most common site for this kind of neoplasm being the spine (65%), followed by the pelvis, skull, and then the long bones [4, 6, 8, 9] . The prognosis for bone metastases in colorectal cancer is bad, with studies showing that the 5-year survival rate is 8.1%, with a median survival rate of 16 months [16] [17] [18] .
Another important aspect is the psychological one. When the average person is faced with the diagnosis of a cancer, the psychological implications are vast. Studies have shown that 87% of the patients develop a form of depression. The discovery of a secondary site further adds stress and tension. Many of them choose to give up and refuse more radical treatment that may prolong or even save their lives. Counseling is imperative, so that the patient can cope better with the reality of this disease, and all that it implies, including the hard decisions that have to be made [5, 10, 13] .
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Conclusions
The most important thing, when up against a tumoral growth, is for the surgeon to do a biopsy of the said tumor. This essential step will determine the correct diagnosis as well as the right choice of treatment.
Another crucial step before choosing any type of treatment is to first treat the primary tumor that gave birth to the metastasis. The evolution of the primary tumor establishes the type of treatment for the subsequent metastases, be it curative if the evolution is good or palliative if it is not.
Last, but not least, all physicians should offer moral support, because patients faced with these diagnoses tend to make wrong decisions that have a potentially vital impact.
